The rate of major hemorrhage among patients in the apixaban group was 2.13 % per year compared with 3.09 % per year in the warfarin group ( hazard ratio [ HR ] 0.69 , 95 % confidence interval [ CI ] : 0.60 to 0.80 ; p < 0.001 ) .